SCHEMBL256519

SCHEMBL256519

CCOc1ccc(C#Cc2ccc(C(C)NC(C)=O)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACACB O00763 20/20 1.00
ACACA Q13085 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11998832 1.00 ACACB (1.00) ACACBACACA
SCHEMBL12475738 0.93 ACACB (0.86) ACACBACACA
SCHEMBL12001364 0.89 ACACB (1.00) ACACBACACA
SCHEMBL256332 0.89 ACACB (1.00) ACACBACACA
SCHEMBL256178 0.88 ACACB (0.92) ACACBACACA
SCHEMBL12001416 0.88 ACACB (0.92) ACACBACACA
SCHEMBL16063371 0.87 ACACB (1.00) ACACB
SCHEMBL256298 0.87 ACACB (1.00) ACACB
SCHEMBL165796 0.87 ACACB (1.00) ACACB
SCHEMBL16063354 0.86 ACACB (1.00) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611771-B1 SUBSTITUTED HETEROARYL- AND ARYLALKYNYL BENZENE DERIVATIVES AS ACC-INHIBITORS FOR THE TREATMENT OF METABOLIC DISEASES BOEHRINGER INGELHEIM INT (DE) 2016-11-23 EP disclosed
US-8835472-B2 Compounds, pharmaceutical compositions and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-09-16 US disclosed
WO-2012028676-A1 NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-03-08 WO disclosed